Chambers Michael Andrew 4
4 · Sarepta Therapeutics, Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Chambers Michael Andrew
Director
Transactions
- Award
Common Stock
2024-03-01+1,846→ 8,277 total - Award
Stock Option (right to buy)
2024-03-01+3,679→ 3,679 totalExercise: $128.67From: 2025-03-01Exp: 2034-03-01→ Common Stock (3,679 underlying)
Holdings
- 246,996(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 1, 2025.